A new study from @biofidelity_dx is examining how its Aspyre technology can bridge the gaps in clinical care that prevent early-stage non-small cell lung cancer (NSCLC) patients from receiving molecular profiling and, as a result, highly effective targeted therapies.
“Advancing genomic testing for early-stage resectable NSCLC patients is crucial, and this study offers two opportunities: additional research about actionable mutations in this population and the assessment of a new platform with the potential to improve patient care,” said Dr. Shetal Patel from the University of North Carolina.
Click here to learn about how you can join this study and help expand testing options for Early-Stage NSCLC.https://t.co/GDFrHV0WQo
"Injustice anywhere is a threat to justice everywhere. We are caught in an inescapable network of mutuality, tied in a single garment of destiny. Whatever affects one directly, affects all indirectly."
-Dr Martin Luther King Jr.
https://t.co/A5kj3eJgPB
#genomics4all#NSCLC
Our CEO spoke with @GenomeWebabout our innovative approach to improve MRD testing and cancer patient monitoring with the new Enspyre® sample enrichment platform.Thanks for the great conversation @forestray!
https://t.co/vIdOZPdhht
#MolecularDiagnostics#NGS#Cancer
Is it time for a simple, fast and reliable test for detection of NSCLC biomarkers from tissue or blood within two days?
Join this webinar hosted by CAPToday on Wed 1/22 at 12pmET by registering at: https://t.co/FKvckqeCkH
#NSCLC#targetedtherapy#pathology@pathologists
Join us on Jan 22 for a webinar: Aspyre Clinical Test for Lung: A Rapid Alternative to Comprehensive Genomic Profiling (CGP)
Hear experts discuss how we've simplified genomic profiling with Aspyre technology. #NSCLC@pathologists
Register today! https://t.co/JcpAbXZRw9
Join our #UK team as a Production Scientist. Play a key role in design transfer, process improvement, & production of molecular diagnostic assays while ensuring quality & compliance. Apply or share: https://t.co/45pfE7b0X1 #hiring#genomics4all
*No recruiter calls, pls*
Members of our Senior Leadership Team will be at #JPM25#JPM2025. If you are interested in learning more about us, please reach out directly or via our events page: https://t.co/Tgsc9bcY6n
We're welcoming some of the newest members of our global team in a series of #WelcomeWednesday posts. This week we're delighted to welcome James!
Interested in learning more about what it's like to work with us? Click here to view our open roles https://t.co/b0VS40qA6o
We're welcoming some of the newest members of our global team in a series of #WelcomeWednesday posts. This week we're delighted to welcome Tatiana!
Interested in learning more about what it's like to work with us? Click here to view our open roles
https://t.co/skVkpTKiUM
Join our UK team as a Senior Production Scientist! Lead design transfer, process improvement, and production of molecular diagnostic assays. Apply here: https://t.co/kigH910312 No recruiter calls. #hiring#UK#genomics4all
Join us for a virtual dinner event to learn about Simplified Genomic Profiling, the only alternative to #NGS that provides fast, simple & reliable detection of #NSCLC biomarkers from tissue or blood w/in 2 days. RSVP today! Hosted w/ the Colorado Society of Clinical Pathologists
Patients w/ resectable stage IB-IIIA, IIIB #NSCLC are typically tested for ALK & EGFR mutations for #neoadjuvanttherapy eligibility. But more actionable mutations may exist. New study aims to identify these, expanding #targetedtreatment options. Learn more https://t.co/XDJ1sTU4bw
We're #hiring an experienced Customer Success Manager to join our #US team to deliver exceptional customer service, build long-term, collaborative relationships with clients, and drive continuous process improvements. Learn more & apply https://t.co/WPiQKqwM4q
#genomics4all